Pharma channel feed

Gilead tracks five years of HIV grant giv­ing in hard-hit US South, and dou­bles down on new ap­proach­es

Last year
Marketing

Blue Shield of Cal­i­for­nia breaks off from phar­ma­cy ben­e­fit man­ag­er in new deal with Ama­zon and Mark Cuban

Last year

Doc­tors With­out Bor­ders re­jects Vi­iV Health­care's pro­posed con­tract for long-act­ing HIV PrEP drug

Last year

DOJ plans to take mifepri­s­tone chal­lenge to the Supreme Court

Last year
FDA+
Law

FDA ap­proves Ipsen's ul­tra-rare dis­ease drug palo­varotene

Last year
FDA+

Ab­b­Vie rais­es aware­ness around men­tal health and skin con­di­tions with pa­tients, docs and a celebri­ty spokesper­son

Last year
Marketing

Mallinck­rodt con­sid­ers Chap­ter 11 as ‘ad­vanced dis­cus­sions’ con­tin­ue

Last year

Flori­da adds ne­glect­ed FOIA re­quests to amend­ed law­suit against FDA over drug im­ports

Last year
FDA+

Te­va tri­al over al­leged Medicare kick­backs stopped while pend­ing ap­peal of po­ten­tial $10B judg­ment

Last year
Law

An­oth­er Eylea com­peti­tor pre­pares to en­ter the ring fol­low­ing pos­i­tive PhI­II read­out

Last year
FDA+

Leg­end im­proves ac­cess to Carvyk­ti, but cell ther­a­py lags de­mand as biotech seeks ear­li­er-line ap­proval

Last year
Cell/Gene Tx

Tetra Pharm opens new head­quar­ters to boost cannabi­noid drug re­search and man­u­fac­tur­ing

Last year
Manufacturing

Sanofi bid first, but Bio­gen won out in fight to ac­quire Rea­ta — re­port 

Last year

Medi­Wound’s US launch of its top­i­cal gel for burns de­layed to Q1 due to man­u­fac­tur­ing ‘de­vi­a­tion’

Last year

Ama­zon Phar­ma­cy de­liv­ers in­sulin dis­counts in new au­to­mat­ic coupon pro­gram

Last year

Bio­con fa­cil­i­ty in Malaysia found to have is­sues once again by the FDA

Last year
FDA+
Manufacturing

Bris­tol My­ers to cut 108 em­ploy­ees in New Jer­sey

Last year
People

FDA pro­mo­tions watch­dog de­liv­ers first warn­ing let­ter of the year to As­traZeneca over Breztri mar­ket­ing

Last year
FDA+
Marketing

Am­i­cus scores an­oth­er ap­proval in the UK for Pompe dis­ease ther­a­py, ex­pects FDA OK in Q3

Last year

Mar­ket­ingRx roundup: Pfiz­er teams with Food Net­work star; Bris­tol My­ers earns 'bil­lion dol­lar' dis­tinc­tion

Last year
Marketing

How Ex­act Sci­ences' out-of-the-box think­ing con­vinced Amer­i­cans to try Co­lo­guard's col­orec­tal can­cer screen­ing test

Last year
Marketing

Re­vance touts first ther­a­peu­tic in­di­ca­tion for Botox ri­val Daxxi­fy in cer­vi­cal dys­to­nia

Last year
FDA+

HHS ham­mers in­dus­try's at­tempt to de­lay new drug price ne­go­ti­a­tions

Last year

Judge strikes down J&J talc unit's sec­ond bank­rupt­cy at­tempt over lack of 'fi­nan­cial dis­tress'

Last year
Law
First page Previous page 106107108109110111112 Next page Last page
A service from the Financial Times